Nuwellis Announces the Submission of the AVOID-HF Clinical Analysis as a Late Breaking Clinical Trial at HFSA
Go back to Nuwellis Announces the Submission of the AVOID-HF Clinical Analysis as a Late Breaking Clinical Trial at HFSA| Baxter International Inc. (NYSE: BAX) | Delayed: 20.10 +0.44 (2.24%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $19.66 | 52 Week High | $50.16 | |||
| Open | $19.50 | 52 Week Low | $34.06 | |||
| Day High | $20.17 | P/E | 5.49 | |||
| Day Low | $19.42 | EPS | $3.66 | |||
| Volume | 5,072,528 | |||||
| (NASDAQ: NUWE) | Delayed: 0.13 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.13 | 52 Week High | $ | |||
| Open | $0.13 | 52 Week Low | $ | |||
| Day High | $0.13 | P/E | N/A | |||
| Day Low | $0.12 | EPS | $ | |||
| Volume | 2,422,908 | |||||
